| <img alt="" height="1" width="1" />Salix Pharmaceuticals Reports 2Q2010 ResultsMarketWatch (press release)Market research indicates healthcare providers and patients are not satisfied with current treatment options for IBS. We believe XIFAXAN550 has the ...Revenue for Salix jumps 80 percent<nobr>News & Observer</nobr>Piper Jaffray Overweight On Salix Pharmaceuticals, Has $58 Target (SLXP)<nobr>Benzinga</nobr>FDA TO REVIEW SALIX IRRITABLE BOWEL SYNDROME DRUG (SLXP)<nobr>Zacks.com</nobr><nobr>PipelineReview.com (press release)</nobr><nobr>all 69 news articles »</nobr> |
Google- Salix Pharmaceuticals Reports 2Q2010 Results - MarketWatch (press release)
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!